Based in Diepenbeek, Belgium, Softhale N.V. is a pharmaceutical company specializing in the development of inhalable respiratory products for the medical treatment of various indications including, for example, Asthma or COPD. In Softhale’s office and labs, the focus lies on product development, formulation development, and analytical capabilities. The team is led by international industry experts (hardware, formulation, analytics, manufacturing, commercialization) and supported by external (inter-)national services providers. The Company’s proprietary, propellant-free, purely mechanical device delivers medication to the lungs more effectively than other types of inhalers and is poised to change the treatment paradigm in large markets including asthma and COPD. Softhale’s products to be used for pharmaceutical development and approval processes are innovative as well as cost-optimized. Softhale is ISO 13485: 2016 certified.